Cleanspace Holdings Ltd (CSX)

CSX Chart

vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Advanced

Show News Mov Avgs 9-day 10-day 20-day 30-day 50-day 100-day 150-day 200-day Mov Avgs 9-day 21-day 30-day 200-day Simple Exponential Weighted Simple Exponential Weighted vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Mov Avgs 10-day 20-day 30-day 50-day 100-day 150-day 200-day 9/21 Cross 10/30 Cross Golden Cross Vol RSI BB

Day 3m 6m 1yr 5yr 10yr

CSX's Principal Activity is the design, manufacture and production of respiratory protection equipment used in the industrial and healthcare sectors.

Announcements

Company Overview

Dividend History

Directors & Management

Name	Title	Since	Bio
Ms Elizabeth Harvey	Chief Financial Officer,Joint Company Secretary	Nov 2020
Ms Elissa Hansen	Joint Company Secretary	Nov 2020
Dr Ronald (Ron) Peter Weinberger	Non-Executive Chairman,Non-Executive Director	Jul 2018	Dr Ronald (Ron) Peter Weinberger Non-Executive Chairman,Non-Executive Director Dr Weinberger has over 20 years' experience commercialising medical devices. Dr Weinberger is the former Executive Director and Chief Executive Officer of Nanosonics (ASX:NAN) where he co-developed Nanosonics' platform technology. He has been Chief Executive Officer of EMVision Ltd (ASX:EMV) since December 2018 and managing director from May 2020. Dr Weinberger has also been a non-executive director and the chairperson of HeraMED Ltd (ASX:HMD) since August 2018. Dr Weinberger will be a member of the Risk Management Committee.
Mr William James Highland	Non-Executive Director	Aug 2015	Mr William James Highland Non-Executive Director Mr Highland was a senior executive and investment manager with 30 years' senior management experience in developing and building companies in Australia, USA, Asia and Europe whilst working with OPSM Protector, BTR Nylex, Boral and CVC Limited. Mr Highland has experience in the production and marketing of respiratory systems for industrial workplaces; resuscitation products for the first response markets; emergency life support systems for the mining and oil and gas markets, and breathing apparatus for the fire and rescue services. Additionally, Mr Highland has served as a director and chief executive officer for The Environmental Group Limited and as a director for SMC Gold Limited and Blue Energy Limited, which are both ASX listed companies, and also as a director and chairman of private companies, and joint venture boards. Mr Highland was Chairperson of the Board of CSX from November 2016 until December 2019. Mr Highland will be a member of the Risk Management Committee.
Dr Alexandra Margaret Birrell	Chief Executive Officer,Executive Director	Aug 2015	Dr Alexandra Margaret Birrell Chief Executive Officer,Executive Director Dr Birrell has worked in senior management roles in the healthcare and technology sector for over 20 years. Her previous roles include PricewaterhouseCoopers where she worked in the healthcare advisory practice and financial services (Technology); and Royal Prince Alfred Hospital. Dr Birrell was a member of the Board of Trustees of Museum of Applied Arts & Sciences, NSW from 2016 - 2019. Dr Birrell is a previous winner of AFR Women of Influence Awards, Chief Executive Women Scholarship.
Mr Dan Kao	Director-Operations & Founder,Executive Director	Apr 2011	Mr Dan Kao Director-Operations & Founder,Executive Director Mr Kao worked in the medical and healthcare industry for over 20 years, and has experience in manufacturing, supply chain optimisation, quality management systems and in securing patents for innovative technologies in healthcare. Mr Kao is a former senior designer for ResMed Inc (Australia) (ASX:RMD). Mr Kao is a previous winner of the Australian Design Award.
Mr Craig Stainton Lawn	Non-Executive Director	Apr 2011	Mr Craig Stainton Lawn Non-Executive Director Mr Lawn was a partner for PricewaterhouseCoopers for over 20 years, where he provided income tax and commercial advice to a various businesses, including biotechnology, venture capital and research based organisations. Further, between January 2017 and December 2019, Mr Lawn was a Non-Executive Director of Tubi Limited which listed on 14 June 2019 (ASX:2BE). In addition to CleanSpace, Mr Lawn is currently on the boards of Key Assets Pty Ltd as the Chairperson and The Red Room Company Ltd as treasurer. Mr Lawn is also a consultant advisor through Good Foundations Pty Ltd and Lawn Corporate Advisory, providing business and strategic advice to charities, private company groups, public bodies and not for profit organisations. Mr Lawn will be Chairman Risk Management Committee.

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Ronald (Ron) Weinberger	03/07/2018	50,454	N/A	113,207	N/A
Alexandra Birrell	10/08/2015	N/A	2,798,962	220,470	N/A
William Highland	10/08/2015	128,915	N/A	113,207	N/A
Craig Lawn	02/03/2015	N/A	1,001,871	113,207	N/A
Dan Kao	01/04/2011	2,530,000	N/A	68,418	N/A

Show All

Top 20 Shareholders About the Data

Name	Shares	Capital
Walsh And Company Investments Limited ( CVC Emerging Companies A/C)	10,007,535	12.99%
National Nominees Limited	5,486,723	7.12%
Group - Bnp Paribas Noms (NZ) Ltd (Drp)	4,605,855	5.98%
HSBC Custody Nominees (Australia) Limited	4,353,203	5.65%
Chatswood Wealth Management Pty Ltd	3,850,000	5.00%
Alex Birrell (Baf A/C)	2,798,962	3.63%
Dan Kao	2,530,000	3.29%
J P Morgan Nominees Australia Pty Limited	2,199,442	2.86%
Min Fang	2,057,248	2.67%
Acorn Capital Private	1,965,166	2.55%
Paftec Investment Fund Pty Ltd (Paftec Unit A/C)	1,940,937	2.52%
Alfred H H Myers (Lucy's A/C)	1,449,481	1.88%
Linda Ying Wang (Kao And Wang Family A/C)	1,202,816	1.56%
CS Third Nominees Pty Limited (HSBC Cust Nom Au Ltd 13 A/C)	1,187,137	1.54%
Craig Lawn & Joy Lawn (Lawn Family Super Fund A/C)	1,001,871	1.30%
Peter Anthony Vogliotti	1,000,000	1.30%
Ching Ming Liu	992,242	1.29%
Washington H Soul Pattinson & Company Limited	986,394	1.28%
HSBC Custody Nominees (Australia) Limited - A/C 2	961,490	1.25%
Clement Patrick Doherty & Jayne Maree Doherty (Doherty Super Fund A/C)	850,000	1.10%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month